Blalock–Hanlon procedure

From WikiMD's Medical Encyclopedia

Revision as of 23:03, 28 February 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Blalock–Hanlon procedure is a surgical procedure used in pediatric cardiology to treat certain types of congenital heart defects. It was first performed by Alfred Blalock and C. Rollins Hanlon in the mid-20th century.

History

The Blalock–Hanlon procedure was first performed in 1948 by Alfred Blalock and C. Rollins Hanlon. The procedure was developed as a palliative treatment for transposition of the great arteries (TGA), a serious congenital heart defect.

Procedure

The Blalock–Hanlon procedure involves creating an atrial septal defect (ASD) in the heart. This is done by removing a portion of the atrial septum, the wall that separates the two upper chambers of the heart. The purpose of this procedure is to allow oxygen-rich blood from the left atrium to mix with oxygen-poor blood in the right atrium. This increases the overall oxygen content of the blood that is pumped to the body.

Indications

The Blalock–Hanlon procedure is indicated for patients with transposition of the great arteries who also have an inadequate or restrictive atrial septal defect. It may also be used in other conditions where increased mixing of blood in the atria is beneficial, such as pulmonary atresia or tricuspid atresia.

Risks and Complications

As with any surgical procedure, the Blalock–Hanlon procedure carries risks. These include bleeding, infection, and damage to the heart or surrounding structures. Long-term complications can include arrhythmias (abnormal heart rhythms) and heart failure.

Alternatives

The Blalock–Hanlon procedure is less commonly performed today, as more definitive surgical treatments for transposition of the great arteries have been developed. These include the arterial switch operation and the Mustard procedure or Senning procedure, which are often preferred due to their lower risk of long-term complications.

See Also

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!




Stub icon
   This article is a cardiovascular system stub. You can help WikiMD by expanding it!




Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.